Massimiliano Camilli
Massimiliano Camilli/LinkedIn

Massimiliano Camilli: PRADA II and EMPATICC Trials in Cardio-Oncology are Live From ESC2025

Massimiliano Camilli, Member of the Atrial Disorders Committee of the Heart Failure Association of the European Society of Cardiology, shared a post on LinkedIn:

“Live now from ESC2025-Randomized Controlled Trials in Cardio-Oncology: PRADA II and EMPATICC Trials simoultaneuosly published and now online.”

Massimiliano Camilli

More posts featuring Massimiliano Camilli.